Sclerosis: Clinical Trials

1 trial for Sclerosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1
Phase 31Terminated 1

Follow Sclerosis: new trials by email Literature Review of Sclerosis trials Research Report on Sclerosis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy Study of Adrenocorticotropin Hormone to Treat Multiple Sclerosis (MS) Relapses After Sub-responding to an Initial 3 Day Course of Intravenous (IV) Methylprednisolone
Methylprednisolone, ACTH, IV placebo - Multiple Sclerosis
Phase 2 / Phase 3TerminatedNeurologique Foundation, Inc.302009-10-012016-03-22

Narrower conditions

Multiple Sclerosis (1)  ·  Recurrence (1)

Broader conditions

Autoimmune Diseases (1)  ·  Autoimmune Diseases of the Nervous System (1)  ·  Demyelinating Autoimmune Diseases, CNS (1)  ·  Demyelinating Diseases (1)  ·  Disease Attributes (1)  ·  Immune System Diseases (1)  ·  Nervous System Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Adrenocorticotropic Hormone (1)  ·  Methylprednisolone (1)  ·  Methylprednisolone Hemisuccinate (1)

Sponsors

Neurologique Foundation, Inc. (1)

Countries

United States (1)

Top investigators

Daniel Kantor, MD (1)